Birdwatch Note
2023-03-07 21:34:51 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
1. Not all Sweden, just this study 2. Although 84% reported persisting problems affecting everyday life at 24 months, there were "significant improvements ..in the prevalence and magnitude of some symptoms/limitations compared with four months post-discharge." https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(23)00013-3/fulltext
Written by 7C7B629A056E86E6488D7E4AC87E37FD46357F5F68DD1878635F9B09AA95E8B5
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1632982396092940288
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1633219683678834688
- noteId - 1633219683678834688
- participantId - 7C7B629A056E86E6488D7E4AC87E37FD46357F5F68DD1878635F9B09AA95E8B5
- noteAuthorParticipantId -
- createdAtMillis - 1678224891003
- tweetId - 1632982396092940288
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 1
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 1. Not all Sweden, just this study 2. Although 84% reported persisting problems affecting everyday life at 24 months, there were "significant improvements ..in the prevalence and magnitude of some symptoms/limitations compared with four months post-discharge." https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(23)00013-3/fulltext
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2023-03-07 21:34:51 UTC (1678224891003) |
1969-12-31 23:59:59 UTC (-1) |
2023-03-09 02:09:52 UTC (1678327792328) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
rated at | rated by | |
2023-03-12 13:22:07 -0500 | 104E8D492BCC49AF731D78E4B9D67B8911AA9E4CE80B897C249839ED2ACD0D61 | Rating Details |
2023-03-10 15:59:00 -0600 | 1E63C4F17963B9C5B4489BFDF29FE99946F4AFDBE9F44C5F9A9F6119EB7A78A4 | Rating Details |
2023-03-07 16:38:36 -0600 | 31C8619F51E0B369D83AF09C4FF32CAB759E66F692B4EFBE3633DBB709E9D5F6 | Rating Details |
2023-03-07 21:57:47 -0600 | 3922021E2B4C1A4B610B8FAFE0447925B4441B7A397CBAE1E446B9DE65C2A8E3 | Rating Details |
2023-03-07 15:56:02 -0600 | 45060ED935D102E05C21C743FE433C0B17B27D8FCF69CED01A2AD3F9AB2815B1 | Rating Details |
2023-03-07 15:44:18 -0600 | 45B8EF43682258D990F1C39DD9C1C131E030B7B116A1A874CAD37AED55F98C04 | Rating Details |
2023-03-09 12:36:54 -0600 | 49E68D0F137FBAADC316EEA761B671D21AE8B4A83C0804FF39800AB057A7583E | Rating Details |
2023-03-07 17:08:24 -0600 | 5AE383585658C14735A8E4AD636E65762F9D151E3D5C0A61D8D72718829B9E29 | Rating Details |
2023-03-07 18:02:18 -0600 | 67A0EB8507E7130BD80496679FF4FF68B88891F87066A7805B58C0314DDBC399 | Rating Details |
2023-03-07 20:39:32 -0600 | 714FF4FE3FDDBE02DFCAED8323641621CD0B3566DE9E7D47BF255495E2BD23F3 | Rating Details |
2023-03-07 16:12:36 -0600 | 7DAF7E766C91C4681BD9E35A65ED1244CD021FD7E551BF6AB85D6DF31D7EAC10 | Rating Details |
2023-03-07 18:01:17 -0600 | 7EDCC808B1B342B2B5F09F2C7EF0928D5F17B8EE2BA585176752DCA495A37BBA | Rating Details |
2023-03-07 17:35:12 -0600 | 94D6F49DC83AD218D6D405C9224306ADA3B6AE0FF56571D96CB7C9E4156C9208 | Rating Details |
2023-03-07 16:24:03 -0600 | 9AD595B701167DE73F25FC67E8E758737FE297EB40C6B14DFA15EAE009148C91 | Rating Details |
2023-03-07 17:01:12 -0600 | ADA7A6B861E84F16A9AC3EE64215DB07837986FF7A1CF25A4D643148B37B51E4 | Rating Details |
2023-03-07 15:59:45 -0600 | B5FEE1C7F02671E2466AE0184315222BE9F827034DA0D608839BE86F8B7D554A | Rating Details |
2023-03-07 16:39:05 -0600 | BCE1617AB1CAE8A24B7EB5E79E218EE63C01A69D41005CA0CD4D289DD3A5A9F8 | Rating Details |
2023-03-07 16:24:02 -0600 | C03CD871A80A2155C7B8B2FBF9671F48B751978E01DE05D8DDBE991B0A8F6C48 | Rating Details |
2023-03-09 14:13:51 -0600 | C378931E048482D2BFDF00DC95644D6377CBCB812C79FF87D77B5E48595B3DA3 | Rating Details |
2023-03-07 17:45:24 -0600 | F6BD995C6586D3157F1C593C9A62039E9DBC943F51F4C116DC56847DB740565A | Rating Details |
2023-03-07 17:01:12 -0600 | Rating Details | |
2023-03-09 12:36:54 -0600 | Rating Details | |
2023-03-10 15:59:00 -0600 | Rating Details | |
2023-03-07 15:44:18 -0600 | Rating Details | |
2023-03-07 18:01:17 -0600 | Rating Details | |
2023-03-07 16:38:36 -0600 | Rating Details | |
2023-03-07 18:02:18 -0600 | Rating Details | |
2023-03-07 15:59:45 -0600 | Rating Details | |
2023-03-09 14:13:51 -0600 | Rating Details | |
2023-03-07 15:56:02 -0600 | Rating Details | |
2023-03-07 17:45:24 -0600 | Rating Details | |
2023-03-07 20:39:32 -0600 | Rating Details | |
2023-03-07 16:12:36 -0600 | Rating Details | |
2023-03-07 21:57:47 -0600 | Rating Details | |
2023-03-07 17:08:24 -0600 | Rating Details | |
2023-03-07 16:39:05 -0600 | Rating Details | |
2023-03-12 13:22:07 -0500 | Rating Details | |
2023-03-07 16:24:02 -0600 | Rating Details | |
2023-03-07 16:24:03 -0600 | Rating Details | |
2023-03-07 17:35:12 -0600 | Rating Details |